AUPH Q4 2019 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29,000+0.0% YoY

Gross Profit

-$13M-45734.5% margin

Operating Income

-$21M-72069.0% margin

Net Income

-$76M-263724.1% margin

EPS (Diluted)

$-0.78

QoQ Revenue Growth

-87.4%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$324M

Total Liabilities

$26M

Stockholders' Equity

$299M

Cash & Equivalents

$306M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29,000	$29,000	+0.0%
Gross Profit	-$13M	-$11M	-22.7%
Operating Income	-$21M	-$15M	-42.5%
Net Income	-$76M	-$15M	-424.1%